Invitrogen Corporation Licenses Geron Corporation Intellectual Property For Development Of Research Tools

CARLSBAD, Calif. & MENLO PARK, Calif.--(BUSINESS WIRE)--June 29, 2006--Invitrogen Corporation (Nasdaq:IVGN - News) and Geron Corporation (Nasdaq:GERN - News) today announced that Invitrogen has licensed Geron intellectual property related to the growth of human embryonic stem cells (hESCs).